Evolution of the Average Target: CRH plc

Evolution of the Target Price: CRH plc

Changes in Analyst Recommendations: CRH plc

62ed.Y9TqUENprghedYgIq6mncyqTbJHki0eyrXBkvGp7KSc.UKLdEjFR8U4VQ_89_u3CGHKiIPun5wn8mwYCjgciX3U0s7UhFBDxQRM0sA~17ccfa1a7c84111a6fcbb3de76bad5ae
Jun. 22 CRH: CRH is about to make its biggest ever M&A. What does it buy? Alphavalue
May. 11 Bernstein Adjusts Price Target on CRH public company to $150 From $145 MT
May. 05 BNP Paribas Adjusts CRH Price Target to $157 From $152, Maintains Outperform Rating MT
May. 04 Oddo BHF reiterates its view on CRH after the earnings release Zonebourse
May. 01 Citigroup Adjusts CRH Price Target to $146 From $159 MT
Apr. 30 CRH: Q1: CRH's buy-and-build machine delivers again Alphavalue
Apr. 22 CRH: Opinion change, from Reduce to Add Alphavalue
Apr. 15 Wells Fargo Upgrades CRH to Overweight From Equalweight, Price Target is $135 MT
Apr. 10 BNP Paribas Adjusts Price Target on CRH to $152 From $160, Maintains Outperform Rating MT
Apr. 09 CRH offers significant upside opportunity, Jefferies says Zonebourse
Mar. 30 Jefferies Adjusts Price Target on CRH to $145 From $151.20, Maintains Buy Rating MT
Mar. 03 JPMorgan Adjusts Price Target on CRH to $140 From $135, Maintains Overweight Rating MT
Feb. 27 Citigroup Adjusts Price Target on CRH public to $159 From $155, Maintains Buy Rating MT
Feb. 23 Oddo BHF adjusted its estimates on CRH Zonebourse
Feb. 20 Loop Capital Adjusts Price Target on CRH public to $143 From $138, Maintains Buy Rating MT
Feb. 20 DA Davidson Adjusts Price Target on CRH public to $120 From $116, Maintains Neutral Rating MT
Feb. 20 Wells Fargo Adjusts Price Target on CRH public to $135 From $133, Maintains Equalweight Rating MT
Feb. 20 CRH: FY 2025: Big cash, bigger ambition Alphavalue
Feb. 19 Stephens Cuts Price Target on CRH public to $135 From $140, Maintains Overweight Rating MT
Jan. 29 Wells Fargo Adjusts Price Target on CRH public company to $133 From $138, Maintains Equalweight Rating MT
Jan. 26 Rothschild & Co. Redburn Adjusts PT on CRH to $146 From $130, Maintains Buy Rating MT
Jan. 23 BNP Paribas Exane Adjusts Price Target on CRH public to $160 From $163, Maintains Outperform Rating MT
Jan. 14 BofA Securities Adjusts Price Target on CRH public company to $145 From $132, Maintains Buy Rating MT
Jan. 14 Davy raises IAG, cuts Jet2; RBC cuts Reckitt AN
Jan. 13 CRH Shares Fall After Wells Fargo Downgrade MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+6.33%
+22.24%
+10.78%
+19.73%
-39.44%
+14.34%
+24.96%
+19.91%
Average +9.86%
Weighted average by Cap. +7.22%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
112.02USD
Average target price
142.95USD
Spread / Average Target
+27.61%
High Price Target
165.00USD
Spread / Highest target
+47.30%
Low Price Target
105.00USD
Spread / Lowest Target
-6.27%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

alphavalue Egor Sonin
Bernstein
BNP Paribas
Citigroup
Wells Fargo Securities
Jefferies & Co.
JPMorgan Chase
DA Davidson
Loop Capital
Stephens Inc.
Rothschild & Co Redburn
BNP Paribas Exane
BofA Securities
UBS
Morgan Stanley
RBC Capital Markets
Berenberg Bank
Deutsche Bank Securities
Truist Securities
Barclays
Stifel Nicolaus
Vertical Research
ODDO BHF
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
112.02USD
Average target price
142.95USD
Spread / Average Target
+27.61%

Quarterly revenue - Rate of surprise